• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盆腔器官脱垂保守治疗中使用阴道子宫托选择的人口统计学、社会经济和功能健康相关因素:一项回顾性研究

Demographic, socioeconomic and functional health-related factors in the selection of vaginal pessaries used for the conservative treatment of pelvic organ prolapse: a retrospective study.

作者信息

Oláh Orsolya, Romics Miklós, Ács Nándor, Cseh Richárd, Nyirády Péter, Majoros Attila

机构信息

Department of Obstetrics and Gynecology, Semmelweis University, Üllői út 78/A, Budapest, H-1082, Hungary.

Department of Urology, Semmelweis University, Üllői út 78/B, Budapest, H-1082, Hungary.

出版信息

BMC Womens Health. 2025 Aug 13;25(1):390. doi: 10.1186/s12905-025-03923-9.

DOI:10.1186/s12905-025-03923-9
PMID:40804384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12344877/
Abstract

BACKGROUND

Vaginal pessary therapy is a well-known conservative treatment of pelvic organ prolapse (POP). According to several national guidelines, pessary therapy should be used as a first-line treatment for pelvic organ prolapse. A distinction is made between pessaries that can be worn permanently or require daily control. This therapy is primarily chosen by elderly patients who are not suitable for surgery or by patients not wishing to undergo surgical treatment. The aim of our study was to investigate what demographic, socioeconomic and functional health-related factors play a role in the choice of the pessary types, and to provide healthcare professionals with guidance on recommending a pessary type to patients based on these factors.

METHODS

115 female patients using vaginal pessaries for POP were included in our study (group I:73 pts used a daily control "cube" pessary (DCP), group II.:42 pts used a long-term wear ring pessary (LTP). Data collection was performed between March 2021 and March 2022 through a personally completed questionnaire or telephone interview. The following factors were investigated: patients' age, fertility, education level, employment status, marital status, independence, hand function, vision, mobility, physical and sexual activity.

RESULTS

A significant difference was found between the DCP and LTP groups in terms of average age (44.9 vs. 75.7 years p < 0.0001), fertility (61.6 vs. 4.6% p < 0.0001), employment status (retired: 18 vs. 100% p < 0.0001), marital status (single: 8.3 vs. 44.1% p < 0.0001) and educational level (highest: 81.9 vs. 25.6% p < 0.0001). In terms of functional health-related factors, such as weakened hand function (1.4 vs. 34.9% p < 0.0001), vision impairment (19.4 vs. 58.1% p < 0.0001), reduced mobility (5.5 vs. 81.4% p < 0.0001), sexual activity ratio (87.5 vs. 0% p < 0.0001), and the level of physical activity (VAS: 9.5 vs. 6.1 p < 0.01) also significant differences were registered between the DCP and LTP groups.

CONCLUSIONS

The choice of the type of vaginal pessary treatment for POP is influenced by many patient-side factors.

TRIAL REGISTRATION

The study was conducted with the approval of the Regional Institutional Scientific and Research Ethics Committee of Semmelweis University (SE RKEB 97/2022).

摘要

背景

阴道子宫托疗法是一种广为人知的盆腔器官脱垂(POP)保守治疗方法。根据多项国家指南,子宫托疗法应作为盆腔器官脱垂的一线治疗方法。可长期佩戴或需每日检查的子宫托有所不同。这种疗法主要由不适合手术的老年患者或不愿接受手术治疗的患者选择。我们研究的目的是调查哪些人口统计学、社会经济和功能健康相关因素在子宫托类型的选择中起作用,并根据这些因素为医护人员向患者推荐子宫托类型提供指导。

方法

我们的研究纳入了115名使用阴道子宫托治疗POP的女性患者(第一组:73名患者使用每日检查的“立方体”子宫托(DCP),第二组:42名患者使用长期佩戴的环形子宫托(LTP))。2021年3月至2022年3月期间,通过个人填写问卷或电话访谈进行数据收集。调查了以下因素:患者的年龄、生育情况、教育水平、就业状况、婚姻状况、独立性、手部功能、视力、行动能力、身体和性活动。

结果

DCP组和LTP组在平均年龄(44.9岁对75.7岁,p<0.0001)、生育情况(61.6%对4.6%,p<0.0001)、就业状况(退休:18%对100%,p<0.0001)、婚姻状况(单身:8.3%对44.1%,p<0.0001)和教育水平(最高:81.9%对25.6%,p<0.0001)方面存在显著差异。在功能健康相关因素方面,如手部功能减弱(1.4%对34.9%,p<0.0001)、视力障碍(19.4%对58.1%,p<0.0001)、行动能力下降(5.5%对81.4%,p<0.0001)、性活动比例(87.5%对0%,p<0.0001)以及身体活动水平(视觉模拟评分法:9.5对6.1,p<0.01),DCP组和LTP组之间也存在显著差异。

结论

POP阴道子宫托治疗类型的选择受许多患者方面因素的影响。

试验注册

本研究经塞梅尔维斯大学地区机构科研伦理委员会批准进行(SE RKEB 97/2022)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4371/12344877/c6eb212983fd/12905_2025_3923_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4371/12344877/b0fd07ecba5d/12905_2025_3923_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4371/12344877/c6eb212983fd/12905_2025_3923_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4371/12344877/b0fd07ecba5d/12905_2025_3923_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4371/12344877/c6eb212983fd/12905_2025_3923_Fig2_HTML.jpg

相似文献

1
Demographic, socioeconomic and functional health-related factors in the selection of vaginal pessaries used for the conservative treatment of pelvic organ prolapse: a retrospective study.盆腔器官脱垂保守治疗中使用阴道子宫托选择的人口统计学、社会经济和功能健康相关因素:一项回顾性研究
BMC Womens Health. 2025 Aug 13;25(1):390. doi: 10.1186/s12905-025-03923-9.
2
Perioperative interventions in pelvic organ prolapse surgery.盆腔器官脱垂手术的围手术期干预措施。
Cochrane Database Syst Rev. 2018 Aug 19;8(8):CD013105. doi: 10.1002/14651858.CD013105.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Effectiveness and safety of a novel, collapsible pessary for management of pelvic organ prolapse.新型可折叠子宫托治疗盆腔器官脱垂的有效性和安全性。
Am J Obstet Gynecol. 2024 Aug;231(2):271.e1-271.e10. doi: 10.1016/j.ajog.2024.05.009. Epub 2024 May 16.
5
Attitudes toward conservative management of pelvic organ prolapse and stress urinary incontinence with vaginal pessaries: A national survey among Israeli obstetricians and gynecologists.以色列妇产科医生对盆腔器官脱垂和压力性尿失禁采用阴道子宫托保守治疗的态度:一项全国性调查
Int J Gynaecol Obstet. 2025 Aug;170(2):844-849. doi: 10.1002/ijgo.70052. Epub 2025 Mar 12.
6
Where to for pelvic organ prolapse treatment after the FDA pronouncements? A systematic review of the recent literature.在美国食品药品监督管理局(FDA)发布相关声明后,盆腔器官脱垂的治疗何去何从?近期文献的系统综述
Int Urogynecol J. 2013 May;24(5):707-18. doi: 10.1007/s00192-012-2025-3. Epub 2013 Jan 10.
7
Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.针对患有或未患有压力性尿失禁的盆腔器官脱垂女性的手术。
Cochrane Database Syst Rev. 2018 Aug 19;8(8):CD013108. doi: 10.1002/14651858.CD013108.
8
Pessaries (mechanical devices) for pelvic organ prolapse in women.用于女性盆腔器官脱垂的子宫托(机械装置)。
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD004010. doi: 10.1002/14651858.CD004010.pub3.
9
Fistulae Secondary to Vaginal Pessary Use for Pelvic Organ Prolapse: A Systematic Review.盆腔器官脱垂使用阴道子宫托继发瘘管:一项系统评价
Int Urogynecol J. 2025 Mar;36(3):491-521. doi: 10.1007/s00192-024-06035-4. Epub 2025 Jan 20.
10
Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial.阴道内应用结合雌激素对盆腔器官脱垂子宫托持续使用的影响:多中心、随机、双盲、安慰剂对照试验
BMJ. 2025 Jun 27;389:e084418. doi: 10.1136/bmj-2025-084418.

本文引用的文献

1
Bilateral posterior Richter sacrospinous fixation with native tissue: Anatomical and functional results and quality of life assessment over 10 years.双侧后路 Richter 骶棘韧带骨固定术结合自体组织:10 年的解剖学、功能结果和生活质量评估。
J Gynecol Obstet Hum Reprod. 2023 Jun;52(6):102575. doi: 10.1016/j.jogoh.2023.102575. Epub 2023 Mar 26.
2
Patient-reported goal achievements after pelvic floor muscle training versus pessary in women with pelvic organ prolapse. A randomised controlled trial.患者报告的骨盆底肌肉训练与阴道子宫托治疗女性盆腔器官脱垂后的目标达成情况。一项随机对照试验。
J Obstet Gynaecol. 2023 Dec;43(1):2181061. doi: 10.1080/01443615.2023.2181061.
3
Management of female pelvic organ prolapse-Summary of the 2021 HAS guidelines.
女性盆腔器官脱垂的管理——2021年澳大利亚卫生服务咨询委员会指南摘要
J Gynecol Obstet Hum Reprod. 2023 Mar;52(3):102535. doi: 10.1016/j.jogoh.2023.102535. Epub 2023 Jan 16.
4
[Conservative and surgical treatments performed for symptomatic pelvic organ prolapse and stress urinary incontinence in Hungary.].[匈牙利针对有症状的盆腔器官脱垂和压力性尿失禁所采取的保守及手术治疗。]
Orv Hetil. 2022 Dec 25;163(52):2072-2078. doi: 10.1556/650.2022.32681.
5
Quality of Life Following Pelvic Organ Prolapse Treatments in Women: A Systematic Review and Meta-Analysis.女性盆腔器官脱垂治疗后的生活质量:一项系统评价和荟萃分析。
J Clin Med. 2022 Dec 1;11(23):7166. doi: 10.3390/jcm11237166.
6
A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.针对有症状的盆腔器官脱垂女性选择子宫托类型的预测模型。
Menopause. 2021 Oct 11;28(11):1279-1286. doi: 10.1097/GME.0000000000001849.
7
Vaginal Pessary for Pelvic Organ Prolapse: A French Multidisciplinary Survey.阴道子宫托治疗盆腔器官脱垂:法国多学科调查。
J Womens Health (Larchmt). 2022 Jun;31(6):870-877. doi: 10.1089/jwh.2021.0229. Epub 2021 Sep 27.
8
Glue mesh fixation in laparoscopic sacrocolpopexy: results at 3 years' follow-up.腹腔镜骶骨阴道固定术中胶网固定:3 年随访结果。
Int Urogynecol J. 2022 Sep;33(9):2533-2541. doi: 10.1007/s00192-021-04764-4. Epub 2021 Mar 20.
9
Guideline No. 411: Vaginal Pessary Use.指南 411:阴道子宫托使用。
J Obstet Gynaecol Can. 2021 Feb;43(2):255-266.e1. doi: 10.1016/j.jogc.2020.11.013. Epub 2020 Nov 26.
10
Pessary evaluation for genital prolapse treatment: From acceptance to successful fitting.子宫托在治疗生殖器脱垂中的评估:从接受度到成功适配。
Neurourol Urodyn. 2020 Nov;39(8):2344-2352. doi: 10.1002/nau.24493. Epub 2020 Aug 26.